At present, the two most extensive activation mechanisms of PI3K/AKT found in human cancer are triggered by receptor tyrosine kinases (RTK) and somatic mutation of specific components of signaling pathways, which are related to tumor growth, angiogenesis, and survival. Here, AKT1 is linked to cancer.